Unaudited Consolidated Balance Sheets - USD ($) $ in Millions		Sep. 30, 2025	Dec. 31, 2024
Current Assets
Cash and cash equivalents		$ 1,440	$ 962
Trade receivables - third party and affiliates		1,038	1,121
Non-trade receivables, net		657	493
Inventories		2,213	2,284
Assets held for sale		471	0
Other assets		271	266
Total current assets		6,090	5,126
Investments in affiliates		1,259	1,217
Property, plant and equipment (net of accumulated depreciation - 2025: $5,078; 2024: $4,562)		5,172	5,273
Operating lease right-of-use assets		372	388
Deferred income taxes		1,347	1,251
Other assets		546	555
Goodwill	[1]	4,170	5,387
Intangible assets, net		3,213	3,641
Total assets		22,169	22,838
Current Liabilities
Short-term borrowings and current installments of long-term debt - third party and affiliates		1,199	1,501
Trade payables - third party and affiliates		1,248	1,228
Liabilities held for sale		62	0
Other liabilities		1,171	1,157
Income taxes payable		47	4
Total current liabilities		3,727	3,890
Long-term debt, net of unamortized deferred financing costs		11,655	11,078
Deferred income taxes		669	923
Uncertain tax positions		230	286
Benefit obligations		402	396
Operating lease liabilities		278	294
Other liabilities		829	408
Commitments and Contingencies
Shareholders' Equity
Common stock, $0.0001 par value, 400,000,000 shares authorized (2025: 170,916,940 issued and 109,504,355 outstanding; 2024: 170,827,196 issued and 109,327,556 outstanding)		0	0
Treasury stock, at cost (2025: 61,412,585 shares; 2024: 61,499,640 shares)		(5,483)	(5,486)
Additional paid-in capital		425	409
Retained earnings		9,861	11,054
Accumulated other comprehensive income (loss), net		(849)	(848)
Total Celanese Corporation shareholders' equity		3,954	5,129
Noncontrolling interests		425	434
Total equity		4,379	5,563
Total liabilities and equity		$ 22,169	$ 22,838

[1] Includes accumulated impairment losses of approximately $2.7 billion in the Engineered Materials segment as of September 30, 2025 and $1.5 billion as of December 31, 2024.